Your browser doesn't support javascript.
loading
Meloxicam treatment disrupts the regional structure of innate inflammation sites by targeting the pro-inflammatory effects of prostanoids.
Schäufele, Tim J; Kolbinger, Anja; Friedel, Joschua; Gurke, Robert; Geisslinger, Gerd; Weigert, Andreas; Pierre, Sandra; Scholich, Klaus.
Afiliação
  • Schäufele TJ; Institute of Clinical Pharmacology, Goethe University Frankfurt, Frankfurt, Germany.
  • Kolbinger A; Institute of Clinical Pharmacology, Goethe University Frankfurt, Frankfurt, Germany.
  • Friedel J; Institute of Clinical Pharmacology, Goethe University Frankfurt, Frankfurt, Germany.
  • Gurke R; Institute of Clinical Pharmacology, Goethe University Frankfurt, Frankfurt, Germany.
  • Geisslinger G; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt, Germany.
  • Weigert A; Fraunhofer Cluster of Excellence Immune-Mediated Diseases CIMD, Frankfurt, Germany.
  • Pierre S; Institute of Clinical Pharmacology, Goethe University Frankfurt, Frankfurt, Germany.
  • Scholich K; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt, Germany.
Br J Pharmacol ; 181(7): 1051-1067, 2024 Apr.
Article em En | MEDLINE | ID: mdl-37823675
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tiazinas / Prostaglandinas Limite: Animals / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tiazinas / Prostaglandinas Limite: Animals / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article